GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Micromet, Inc. (MITI) [hlAlert]

Micromet, Inc. (Micromet) is a biopharmaceutical company developing antibodies for the treatment of cancer, inflammation and autoimmune diseases. Its product development pipeline includes antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. Four of the Company's antibodies are in clinical trials,
while the remainder of its product pipeline is in pre-clinical development. The Company?s BiTE antibody blinatumomab, known as MT103, is being evaluated in a phase II clinical trial for the treatment of patients with acute lymphoblastic leukemia (ALL), and in a phase I clinical trial for the treatment of patients with non-Hodgkin?s lymphoma (NHL). A second BiTE antibody, MT110, is being tested in a phase I clinical trial for the treatment of patients with solid tumors. MT110 binds to the epithelial cell adhesion molecule (EpCAM), which is over-expressed in many solid tumors.
.
( Total: 9 Current Stock Recommendations )
Micromet, Inc.   (9)
Hold 33% Buy 67%
Related companies
China Biologic ...   (4)
Buy 100%
BioSpecifics ...   (5)
Buy 100%
PROLOR Biotech, Inc.   (5)
Buy 100%
Opko Health Inc   (2)
Buy 100%
Flamel Technologies ...   (8)
Buy 100%
Aeterna Zentaris, ...   (12)
Buy 100%
Lannett Co Inc   (4)
Buy 100%
Anika Therapeutics ...   (4)
Buy 100%
Emergent ...   (6)
Buy 100%
Insys Therapeutics ...   (4)
Buy 100%
Show  

Date (ET)MemberRatingYTD
Gains
 
4/6/2011  
Buy
  
11/15/2010  
Buy
  
1/27/2012  
Hold
  
3/10/2008  
Buy
  
1/27/2012  
Hold
  
12/2/2009  
Hold
  
4/6/2011  
Buy
  
3/25/2009  
Buy
  
2/4/2010  
Buy
  

* As of 8/27/2015 12:00 AM
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy